Metachromatic Leukodystrophy - Type II (Juvenile Form) metachromatic leukodystrophy type II. Select Another Disease One of a group of genetic disorders called the leukodystrophies that affect the growth of http://www.lysosomallearning.com/healthcare/about/lsd_hc_abt_leukodystrophy2.asp
Metachromatic Leukodystrophy - Type I (Late Infantile Form) metachromatic leukodystrophy type I. Select Another Disease One of a group of genetic disorders called the leukodystrophies that affect the growth of http://www.lysosomallearning.com/healthcare/about/lsd_hc_abt_leukodystrophy1.asp
Show-documents.asp metachromatic leukodystrophy Written Information. Care Treatment. Metachromatic Leukodystropy New Search Contact Us Disclaimer Send this link http://www.clevelandclinic.org/health/search/do-query.asp?TopicId=1326
Show-documents.asp metachromatic leukodystrophy Written Information. Care Treatment. , Metachromatic Leukodystropy New Search Health Extra Menu. http://www.clevelandclinic.org/healthextra/do-query.asp?TopicId=1326
Metachromatic Leukodystrophy There are three distinct forms of metachromatic leukodystrophy (late infantile, Absence of an enzyme is responsible for metachromatic leukodystrophy. http://tjsamson.client.web-health.com/web-health/topics/GeneralHealth/generalhea
Extractions: Neurological Metachromatic Leukodystrophy There are three distinct forms of metachromatic leukodystrophy (late infantile, juvenile, and adult). Each differs in its age of onset, symptoms, as well as expected survival. Metachromatic Leukodystrophy What is metachromatic leukodystrophy? There are three forms of metachromatic leukodystrophy: Late Infantile Juvenile Adult
Extractions: Home Back to Health Library Print This Page ... Email to a Friend Definition: Metachromatic leukodystrophy is an inherited disease characterized by the absence of the enzyme arylsulfatase A, which causes a material called cerebroside sulfate to accumulate in cells. This is toxic to the cell, especially neurons (the cells of the nervous system) and causes the problems of the disease. MLD is a member of a class of diseases called lysosomal storage disorders. In these diseases, patients lack a protein needed to metabolize the food we eat. Causes, incidence, and risk factors: Metachromatic leukodystrophy (MLD) is transmitted as an autosomal recessive trait, which means that a person must inherit the defective gene from both parents to be affected. MLD has a wide range of symptoms. As with many other storage diseases, there are forms of early and delayed onset (late infant, juvenile, and adult types). The most common and most severe form is the late infant onset form, which has symptoms such as
Extractions: Vol. 97 No. 8, August 1979 Featured Link E-mail Alerts ARTICLE Article Options Send to a Friend Readers Reply Submit a reply Similar articles in this journal Literature Track Add to File Drawer Download to Citation Manager PubMed citation Articles in PubMed by Libert J Green WR Contact me when this article is cited J. Libert, F. Van Hoof, D. Toussaint, H. Roozitalab, K. R. Kenyon and W. R. Green
Extractions: Sherri jtwogood 06-26-2004, 01:21 PM I'm not that that familiar with the childhood versions of this disease but I have the adult form - AMN adrenomyeloneuopathy or ALD adrenoleukodystrophy. I do know that the Kennedy Kreiger Institute http://www.kennedykrieger.org/ is one of the leading research locations for this disease in Baltimore, MD. It's part or related to John Hopkins. I went there when they were testing Lorenzo's Oil on aldults. Later I was told it wasn't effective for aldults but worked well for children and those that hadn't shown symptoms. I would contact them. The ULF is another place to look for information. If I can help any further please feel free to email me. Good luck and God Bless.
IngentaConnect Gene Therapy Of Metachromatic Leukodystrophy metachromatic leukodystrophy (MLD) is a lysosomal storage disease that is caused by a deficiency of arylsulfatase A (ASA). The deficiency results in the http://www.ingentaconnect.com/content/apl/ebt/2005/00000005/00000001/art00005
Extractions: For Researchers For Librarians Authors: Ulrich Matzner; Volkmar Gieselmann Source: Expert Opinion on Biological Therapy , Volume 5, Number 1, 1 January 2005, pp. 55-65(11) Publisher: Ashley Publications View Table of Contents full text options Abstract: Keywords: arylsulfatase A gene therapy lysosomal storage disease mannose 6-phosphate ... metachromatic leukodystrophy Document Type: Review article DOI: The full text article is available for purchase $75.00 plus tax The exact price (including tax) will be displayed in your shopping cart before you check out. You will be able to remove this item from your shopping cart at any time before you have completed check-out. View Table of Contents Back to top Terms and Conditions Page Help Quick Search
Extractions: For Researchers For Librarians Authors: V Gieselmann ; S Franken ; D Klein ; JE Mansson ; R Sandhoff ; D Hartmann ; VPM Saravanan ; PP De Deyn ; AM Van Der Linden ; N Schaeren-Wiemers Source: Acta Paediatrica , Volume 92, Supplement 443, Supplement 443/December 2003, pp. 74-79(6) Publisher: Taylor and Francis Ltd View Table of Contents full text options Free trial available! Abstract: Metachromatic leukodystrophy is a lysosomal lipid storage disorder. It is caused by mutations in the gene for arylsulphatase A, an enzyme involved in the degradation of the sphingolipid 3 -O-sulphogalactosylceramide (sulphatide). This membrane lipid can be found in various cell types, but in particularly high concentrations in the myelin of the nervous system. Patients suffer from progressive, finally lethal, demyelination due to accumulation of sulphatide. In the nervous system, lipid storage not only affects oligodendrocytes but also neurons and, in addition, leads to astrogliosis and activation of microglia. At the cellular level, lysosomal sulphatide storage also affects the lipid composition of myelin itself and has consequences for the amount and localization of particular myelin membrane-associated proteins. Here we review data, largely based on an arylsulphatase A knock-out mouse model of metachromatic leukodystrophy.
Edcenter.med.cornell.edu/CUMC_PathNotes/Neuropatho metachromatic leukodystrophyComplete online version of The Encyclopaedia of Medical Imaging including text and images from The Encyclopaedia of Medical Imaging s eight book volumes http://edcenter.med.cornell.edu/CUMC_PathNotes/Neuropathology/Neuropath_II/metab
Extractions: Lack of blood supply and/or lack of adequate oxygen delivery causes hypoxic damage to the nervous system: for example, post cardiac-arrest encephalopathy. The brain has a high metabolic demand reflected in the large proportion of cardiac output which it receives. Thus mild decreases in cerebral blood flow or oxygenation can cause changes in brain function. If the patient survives, there will be demyelination of white matter in the centrum semiovale after several days have passed. Thus the patient may awaken feeling fine and develop neurologic symptoms days later ("postanoxic delayed demyelination"). This is thought to occur because oligodendrocytes suffer hypoxic injury. Because the metabolic turnover of myelin is slow, symptoms don't develop for days.
Extractions: Search Health Information Talk To A Nurse: My Nurse Specialized Outpatient Services Patient Education Materials ... Contact A Nurse Search Health Information August 02, 2005 Back to Search Definition Metachromatic leukodystrophy is an inherited disease characterized by the absence of the enzyme arylsulfatase A, which causes a material called cerebroside sulfate to accumulate in cells. This is toxic to the cell, especially neurons (the cells of the nervous system) and causes the problems of the disease. MLD is a member of a class of diseases called lysosomal storage disorders. In these diseases, patients lack a protein needed to metabolize the food we eat. Alternative Names MLD; Arylsulfatase A deficiency Causes And Risk Metachromatic leukodystrophy (MLD) is transmitted as an autosomal recessive trait, which means that a person must inherit the defective gene from both parents to be affected. MLD has a wide range of symptoms. As with many other storage diseases, there are forms of early and delayed onset (late infant, juvenile, and adult types). The most common and most severe form is the late infant onset form, which has symptoms such as
Extractions: OF THE CD Metachromatic Leukodystrophy, Late Juvenile and Adult Onset Inheritance: Autosomal recessive Frequency: Heterozygote prevalence estimated at ~1% Homozygote incidence estimated at ~1 in 40,000 in the United States Locus: ARSA gene at 22q13.31-qter (arylsulfatase A) Defining characteristics: Progressive deterioration of motor and neurocognitive function Demyelination of axons and peripheral nerves Mental deterioration Late Juvenile and Adult (6+ years of age) Decreased work or school performance, behavioral changes, memory loss, possible seizures, psychoses, gradual loss of motor skills, optic atrophy
Nradnormal.html metachromatic leukodystrophy. Back to Other Directory Back to Neuroradiology Directory Back to Home. http://www.uiowa.edu/~c064s01/nr287.htm
Biospace Glossary: Definitions metachromatic leukodystrophy. Sponsored by Society for In Vitro Biology (SIVB). A genetic disorder caused by a deficiency of the enzyme arylsulfatase A. http://www.biospace.com/gls_detail.cfm?t_id=105615
Extractions: Departamento de genetica humana, Fac. de Medicina, U.A.N.L. Lab. clinico-medicos, Dr. Moreira Centro de investigacion biomedica del noreste, Monterrey, N.L., Mexico Metachromatic leukodystrophy (MLD) is an autosomal recessive disorder characterized by progressive degeneration of the central nervous system. The disease is caused by mutations in the arylsulphatase A gene (ASA), located at 22q13.31 (OMIM 250100). The ocurrence of MLD is approximately 1:40,000. There are three clinical forms of MLD: late infantile, juvenile and adult. We describe the case of a boy died when he was 11 year old, diagnosed with the late infantile form of MLD because a clinical picture of progressive neurologic deficit since he was 9 y.o. and low levels of ASA enzimatic activity in serum and urine. Levels of ASA in the other members of the family showed decreased activity in his father and two sisters and normal activity in his mother and two brothers. The patient's parents are non-consanguineous. Biochemical findings suggest paternal disomy for a mutation in the proband and heterozygocity for the same genetic defects in his father and sisters. Uniparental disomy ocurrs in some mendelian disorders when the set of genes or chromosomes are derived exclusively from only one parent. So far, this genetic mechanism has not been describen for MLD.
[DYSPHAGIA] Metachromatic Leukodystrophy Kelly Well, metachromatic leukodystrophy is an inherited disorder and, See ff metachromatic leukodystrophy Infantile form onset by age 2, http://list.dysphagia.com/dysphagia/2002-January/msg00165.html
Extractions: Date Prev Date Next [Chronological] [Thread] ... [Top] http://promo.yahoo.com/videomail/ - To UNSUBSCRIBE from this list, please send an e-mail message to majordomo@medonline.com with the following text as a message: unsubscribe dysphagia - References [DYSPHAGIA] Metachromatic Leukodystrophy From: Kelly_Moore@shepherd.org (Kelly Moore) Prev by Date: [DYSPHAGIA] Metachromatic Leukodystrophy Next by Date: [DYSPHAGIA] OI and swallowing Index(es): Chronological Thread
[DYSPHAGIA] Metachromatic Leukodystrophy Subject DYSPHAGIA metachromatic leukodystrophy; From ROBERT_VOLIN@NYMC.EDU (VOLIN ROBERT); Date Fri, 25 Jan 2002 111742 0500 http://list.dysphagia.com/dysphagia/2002-January/msg00278.html
Extractions: Date Prev Date Next [Chronological] [Thread] ... [Top] see the following for brief information about metachromatic leukodystrophy. If your patient has this diagnosis, his problems have little to do with the MVA of 1966. http://www.ninds.nih.gov/health_and_medical/disorders/meta_leu_doc.htm Prev by Date: [DYSPHAGIA] NPO Next by Date: [DYSPHAGIA] metabolic myopathy Index(es): Chronological Thread